Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,004 | 3 | 64.0% |
| Honoraria | $3,200 | 2 | 18.6% |
| Travel and Lodging | $2,669 | 9 | 15.5% |
| Food and Beverage | $314.20 | 9 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $6,171 | 3 | $0 (2018) |
| PTC Therapeutics, Inc. | $4,167 | 8 | $0 (2019) |
| Omeros Corporation | $3,590 | 10 | $0 (2019) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $2,560 | 1 | $0 (2020) |
| Y-mAbs Therapeutics, Inc. | $700.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $700.00 | 1 | Y-mAbs Therapeutics, Inc. ($700.00) |
| 2020 | $2,560 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($2,560) |
| 2019 | $7,757 | 18 | PTC Therapeutics, Inc. ($4,167) |
| 2018 | $6,171 | 3 | GENZYME CORPORATION ($6,171) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/11/2021 | Y-mAbs Therapeutics, Inc. | DANYELZA (Drug) | Honoraria | Cash or cash equivalent | $700.00 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2020 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug), MAYZENT | Consulting Fee | Cash or cash equivalent | $2,560.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2019 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 11/16/2019 | PTC Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $995.99 | General |
| 11/16/2019 | PTC Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $125.06 | General |
| 11/16/2019 | PTC Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $114.00 | General |
| 11/16/2019 | PTC Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/16/2019 | PTC Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $37.85 | General |
| 11/16/2019 | PTC Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 11/16/2019 | PTC Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $8.97 | General |
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Travel and Lodging | In-kind items and services | $523.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Travel and Lodging | In-kind items and services | $276.64 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Travel and Lodging | In-kind items and services | $98.82 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $49.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $42.85 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Omeros Corporation | narsoplimab (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Immunology | ||||||
| 01/04/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $5,644.00 | General |
| 01/04/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $378.46 | General |
| 01/04/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $148.35 | General |
About Dr. John Knispel, MD
Dr. John Knispel, MD is a Obstetrics & Gynecology healthcare provider based in Riviera Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1508349556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Knispel, MD has received a total of $17,187 in payments from pharmaceutical and medical device companies, with $700.00 received in 2021. These payments were reported across 23 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($11,004).
Practice Information
- Specialty Obstetrics & Gynecology
- Location Riviera Beach, FL
- Active Since 09/14/2018
- Last Updated 09/14/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508349556
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $6,171
- narsoplimab (Drug) $3,590
- GILENYA (Drug) $2,560
- DANYELZA (Drug) $700.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.